We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
251
Dyne Therapeutics
DYN
$4.89B
$530K 0.04%
29,219
+5,946
+26% +$103K
SUPN icon
252
Supernus Pharmaceuticals
SUPN
$2.78B
$526K 0.04%
10,175
-2,168
-18% -$110K
IDYA icon
253
IDEAYA Biosciences
IDYA
$3.56B
$519K 0.04%
15,583
+1,298
+9% +$43.5K
ARQT icon
254
Arcutis Biotherapeutics
ARQT
$3.3B
$519K 0.04%
22,011
+2,051
+10% +$52.3K
TWST icon
255
Twist Bioscience
TWST
$7.85B
$517K 0.04%
10,880
+916
+9% +$41.1K
RMBS icon
256
Rambus
RMBS
$11B
$516K 0.04%
6,000
-1,000
-14% -$99.8K
SRPT icon
257
Sarepta Therapeutics
SRPT
$1.94B
$513K 0.04%
23,595
+6,520
+38% +$126K
EYPT icon
258
EyePoint Inc
EYPT
$1.17B
$512K 0.04%
39,691
+10,201
+35% +$153K
VERA icon
259
Vera Therapeutics
VERA
$2.16B
$509K 0.04%
12,663
+2,246
+22% +$96.8K
TNGX icon
260
Tango Therapeutics
TNGX
$4.31B
$500K 0.04%
23,900
+1,954
+9% +$27.2K
ALMS
261
Alumis Inc
ALMS
$3.26B
$494K 0.04%
22,436
+6,596
+42% +$165K
STOK icon
262
Stoke Therapeutics
STOK
$2.13B
$493K 0.04%
15,136
+2,229
+17% +$73.1K
RBRK icon
263
Rubrik
RBRK
$19.9B
$490K 0.04%
10,000
+1,500
+18% +$86.1K
CSGP icon
264
CoStar Group
CSGP
$12.4B
$476K 0.04%
11,809
-185
-2% -$9.63K
NTRA icon
265
Natera
NTRA
$45.5B
$466K 0.04%
2,330
+730
+46% +$157K
VCYT icon
266
Veracyte
VCYT
$3.59B
$454K 0.03%
14,101
+1,220
+9% +$45.2K
NIO icon
267
NIO
NIO
$11.4B
$452K 0.03%
75,000
– –
TXG icon
268
10x Genomics
TXG
$7.52B
$443K 0.03%
20,882
+1,903
+10% +$38K
BEAM icon
269
Beam Therapeutics
BEAM
$2.76B
$431K 0.03%
18,075
+1,540
+9% +$42.7K
NTLA icon
270
Intellia Therapeutics
NTLA
$1.69B
$429K 0.03%
33,464
+14,590
+77% +$186K
BCRX icon
271
BioCryst Pharmaceuticals
BCRX
$2.71B
$424K 0.03%
44,507
+10,199
+30% +$79.2K
GRAL
272
GRAIL Inc
GRAL
$3.08B
$422K 0.03%
8,168
+216
+3% +$16.7K
ORKA
273
Oruka Therapeutics
ORKA
$7.11B
$421K 0.03%
8,591
+703
+9% +$24.4K
KOD icon
274
Kodiak Sciences
KOD
$2.72B
$413K 0.03%
10,834
+2,190
+25% +$56.6K
ELVN icon
275
Enliven Therapeutics
ELVN
$4.24B
$413K 0.03%
10,532
+861
+9% +$23.9K
9 10
11
12 13

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.